Business
Trump’s 50% tariffs on India take effect: Industry analysts warn of fallout as export hubs brace for pain; trade deal still in limbo— key takeaways – Times of India

NEW DELHI: The additional 25 per cent tariff imposed by US President Donald Trump on Indian goods over New Delhi’s purchases of Russian oil have come into effect, raising the overall levy on exports to 50 per cent.Trump had first announced reciprocal tariffs of 25 per cent on India from August 7, alongside similar levies on about 70 other countries. He later doubled tariffs on Indian goods to 50 per cent, citing Russian crude imports, but allowed a 21-day window for negotiations.
Who’ll pay the price?
Several sectors, including textiles and apparels, gems and jewellery, seafood (primarily shrimp), and leather goods, are set to be affected by the newly imposed tariffs. The Indian pharmaceutical industry, a crucial supplier of generic drugs to the US, along with electronics and smartphones, including Apple iPhones, have been exempted from the tariffs. While some of the tariff costs may be absorbed by Indian exporters through price reductions and US importers by incurring higher expenses, the tariffs are expected to render Indian exports less competitive compared to exporters from neighbouring countries that face tariffs in the 10–25 percent range. The resulting decline in orders from the US, India’s largest market for these products, is anticipated to adversely impact hundreds of MSMEs (micro, small and medium enterprises), leading to layoffs and increased unemployment.
Exemptions and transit Clause
Indian products already “loaded on a ship and in transit” to the US before the August 27 deadline will be exempt from the additional 25 per cent duty, provided they are cleared for consumption by September 17, 2025, and importers declare the special code HTSUS 9903.01.85 to US Customs, DHS said.
FIEO sounds alarm as US tariffs bite
Apex exporters body Federation of Indian Export Organisations (FIEO) on Tuesday had warned that steep US tariffs have forced textile and apparel manufacturers in Tirupur, Noida, and Surat to halt production, reported PTI.President S C Ralhan said about $47–48 billion worth of India’s exports to the US now face 30–35 per cent cost disadvantages, making them uncompetitive against rivals from Vietnam, Bangladesh and China. Labour-intensive sectors like leather, shrimp and handicrafts are also at risk.He urged immediate support through cheaper credit, loan moratoriums, and faster trade deals, while stressing urgent diplomatic engagement with Washington.Also read: Indian refiners unlikely to stop Russia crude oil trade under US pressure
India stays firm
The government has ruled out retaliation but is preparing measures to cushion exporters from the 50% US tariffs. Senior officials told ET that a Rs 25,000-crore Export Promotion Mission is under consideration, covering trade finance, SEZ reforms, warehousing, ecommerce hubs, and “Brand India” promotion. Commerce minister Piyush Goyal said India will protect domestic interests through GST tweaks to boost demand in sectors like textiles and food processing, while also diversifying trade ties with other economies.Earlier, on Monday, Prime Minister Narendra Modi had said he could not compromise on the interests of farmers, cattle-rearers, and small-scale industries. “Pressure on us may increase, but we will bear it,” he asserted. India had described the US move as “unjustified and unreasonable.”
Experts call it a ‘lose-lose’
Trade experts warned the escalation risks damaging both economies. Mark Linscott, Senior Advisor with The Asia Group, was quoted by that “unfortunately”, the US and India have managed to convert what appeared to be a true and unprecedented win-win on trade into a “remarkable lose-lose.”“Hopefully, we will find a way to conclude a satisfactory mutually beneficial Free Trade Agreement with the United States early rather than late and that would certainly take us to the next step of the visit of President Trump to India,” said former foreign secretary and Rajya Sabha MP Harsh Vardhan Shringla.Meanwhile, Raj Manek, Executive Director and Board Member of Messe Frankfurt Asia Holdings Ltd stated India must intensify its focus on innovation and sustainability to achieve its $100 billion target in textiles. He stressed that investment in man-made fibres (MMF) and performance fabrics would be critical at this stage. “Over 60 per cent of global fibre consumption is now in MMF. With the PLI scheme targeting MMF apparel and technical textiles, India is well-positioned to build scale and future-ready capacity,” Manek said after the conclusion of the 13th edition of Gartex Texprocess India, a tradeshow on garment and textile machinery held in the capital, as reported by ET. He added, “At the same time, adopting energy-efficient machinery, managing effluents effectively, and converting waste into value will help meet ESG expectations while lowering costs.”
Indian refiners unlikely to stop Russia crude oil trade
Indian refineries are continuing their imports of Russian crude despite the Trump administration’s 25 per cent additional tariffs, with officials indicating minimal likelihood of halting purchases. Executives told ET that September-loading cargoes were slightly lower due to reduced discounts on Russian oil, but October volumes could rise as prices adjust. They stressed that there are no official instructions to stop procurement, reflecting the government’s clear message of “country first, commerce later.” Officials, including PM Narendra Modi, External Affairs Minister S Jaishankar, and Commerce Minister Piyush Goyal, have conveyed that India will support exporters through challenges rather than yield to US pressure. Industry representatives also noted that while transitioning from Russian oil is technically feasible, rapid changes are unnecessary as supply lines and global markets remain stable.Also read: India prepares multi-pronged strategy to shield economy; details here
Blow to the US too?
The tariff shock is also expected to hit the American economy. According to a report by the State Bank of India (SBI), US GDP could be shaved by 40–50 basis points, while inflationary pressures are likely to rise due to higher input costs and a weaker dollar.Also read: 50% tariffs on India to blowback on Trump? US GDP could shrink 40–50 bps, inflation to flare “We believe that US tariffs are likely to affect US GDP by 40–50 bps along with higher input cost inflation,” the SBI report noted. Import-sensitive sectors such as electronics, automobiles, and consumer durables are already feeling the strain. The report added that US inflation is expected to remain above the Federal Reserve’s 2 per cent target through 2026, driven by tariff pass-through and currency effects.
Trade deal still in limbo
Talks on a bilateral trade agreement (BTA) between India and the US have stalled, with the American delegation having postponed its scheduled August 25 visit to New Delhi.US Treasury Secretary Scott Bessent has accused India of “profiteering” by reselling Russian oil, while trade talks between the two sides remain on “thin ice,” according to experts. Analysts warn that unless Prime Minister Modi and President Trump engage directly, chances of reviving the deal remain slim. The deadlock raises uncertainty for exporters, who had earlier hoped for tariff relief through a limited trade pact.
Business
Indigo Shares Decline Over 4% On Promoter Offloading Stake

Mumbai: The shares of InterGlobe Aviation, the parent company of IndiGo Airlines, tanked over 4 per cent in the early trading on Thursday on news of promoter Rakesh Gangwal’s family selling stocks worth Rs 7,085 crore through a block deal.
At around 11:38 am, the shares were trading at Rs 5,789.0, down 4.31 per cent or Rs 261.
The promoter family is likely to sell 1.2 lakh shares, worth Rs 7,085 crore, at an average price of Rs 5,830 per share.
(Also Read: Key Financial Rules Changing From September 2025)
According to earlier media reports, the Gangwal family plans to sell up to 3.1 per cent of InterGlobe Aviation through block deals valued at approximately Rs 7,020 crore.
A floor price of Rs 5,808 per share, or about 4 per cent less than the closing price of the previous session, was anticipated for the block deal.
With this, the family’s persistent withdrawal from IndiGo continues.
They have been reducing their stake in the airline since Rakesh Gangwal left the board in February 2022; as of 2025, they have sold almost 9 per cent of the company.
(Also Read: What Is GST Compensation Cess? GST Council May End It By October 31)
By reducing their ownership of InterGlobe Aviation, Rakesh Gangwal and his family have raised more than Rs 45,300 crore since 2022.
In September 2022, a 2.74 per cent stake worth Rs 2,005 crore was sold. In February 2023, his wife, Shobha Gangwal, sold a 4 per cent stake for Rs 2,944 crore, and in August 2023, a further 2.9 per cent stake was sold for slightly more than Rs 2,800 crore.
Despite a 4.7 per cent increase in revenue, IndiGo recently reported a 20 per cent year-over-year drop in net profit for the first quarter of FY26, with earnings of Rs 2,176 crore.
Higher fuel prices, exchange rate fluctuations, and other external factors were the primary causes of the decline in profitability.
However, the airline continued to demonstrate strong operational performance, as evidenced by its 84.2 per cent passenger load factor and 87.1 per cent on-time performance.
Business
Top stocks to buy today: Stock recommendations for August 28, 2025 – check list – The Times of India

Top stock market recommendations: According to Aakash K Hindocha, Deputy Vice President – WM Research, Nuvama Professional Clients Group, Nykaa, Kaynes, and Dr Reddy’s Laboratories are the top buy calls for today. Here’s his view on Nifty, Bank Nifty and the top stock picks for August 28, 2025:Index View: NiftyAfter an inside bar formation on Monday, Nifty opened with a gap down reeling all throughout the session ahead of its trading holiday on Wednesday. The index has closed below its trailing support of 24800 allowing for further downside to be opened for 24500 / 24350. Nifty has also formed a bearish head and shoulders formation on daily charts with a neck line support seen at 24450. A break below the same post monthly expiry could reel in further pressure on the index.Bank NiftyUnderperforming Nifty, Bank has broken its support of 55050 opening for a test of sub 54000 odd levels to begin with. The index has also closed at a 3.5 month low on daily charts ahead of its monthly expiry scheduled on Thursday. 55000 is likely to act as resistance on the upside while the index slides below sub 54000 levels in the coming week.NYKAA (BUY):
- LCP: 231.65
- Stop Loss: 223
- Target: 252
Stock has been gaining traction ever since its 3 year triangle breakout seen in June 2025. For now NYKAA has given the highest ever close in past 3 years of trading along with a huge cup and handle breakout on daily and weekly charts. This opens up for a 18-20% trading buy target on the stock, yet we would advise for an initial uptick being 250+ on this leg.KAYNES (BUY):
- LCP: 6197
- Stop Loss: 5980
- Target: 6620
After a cup and handle breakout in early August 2025, stock has been consolidating near the breakout zone for the past 4 weeks now. Last week’s price action suggests further move northwards from CMP as the stock has completed multiple retests of its ongoing breakout.Dr Reddy’s Laboratories (BUY):
- LCP: 1263
- Stop Loss: 1230
- Target: 1355
Sustaining above its 200 DMA support, DRREDDY’s has also given a bullish flag breakout on daily charts. This allows its initial upside to open for the 1350-1360 zone where it could meet another potential breakout on upside.(Disclaimer: Recommendations and views on the stock market and other asset classes given by experts are their own. These opinions do not represent the views of The Times of India)
Business
White House fires CDC director Monarez after she refuses to resign; 4 top health officials quit

Susan Monarez, President Donald Trump’s nominee to be the Director of the Centers for Disease Control and Prevention (CDC), testifies during her confirmation hearing before the Senate Committee on Health, Education, Labor, and Pensions in the Dirksen Senate Office Building on June 25, 2025 in Washington, DC.
Kayla Bartkowski | Getty Images
The White House on Wednesday said it had fired Centers for Disease Control and Prevention Director Susan Monarez after she refused to resign. Four other top CDC officials announced they were quitting the embattled health agency.
The leadership crisis at CDC erupted the same day the Food and Drug Administration announced new limits on who can get the latest approved round of Covid vaccines in the U.S.
“Susan Monarez is not aligned with the President’s agenda of Making America Healthy Again,” White House Spokesman Kush Desai said in a statement to NBC News. “Since Susan Monarez refused to resign despite informing [Health and Human Services Department] leadership of her intent to do so, the White House has terminated Monarez from her position with the CDC.”
The statement comes hours after attorney Mark Zaid said he was representing Monarez and that she had not actually been fired yet or stepped down, adding that she would not resign.
“When CDC Director Susan Monarez refused to rubber-stamp unscientific, reckless directives and fire dedicated health experts, she chose protecting the public over serving a political agenda,” Zaid said in a statement. “For that, she has been targeted.”
Earlier on Wednesday, HHS said in a post on X that “Monarez is no longer director” of the agency.
Monarez, a longtime federal government scientist, was sworn in on July 31. She is the first CDC director to be confirmed by the Senate following a new law passed during the pandemic that required lawmakers to approve nominees for the role.
The Washington Post first reported her ousting on Wednesday.
At least four other officials also submitted their resignations on Wednesday in a massive shakeup at the agency: Dr. Debra Houry, the CDC’s chief medical officer; Dr. Demetre Daskalakis, director of the National Center for Immunization and Respiratory Diseases; Dr. Daniel Jernigan, the director of the National Center for Emerging and Zoonotic Infectious Diseases; and Dr. Jennifer Layden, director of the Office of Public Health Data, Surveillance and Technology.
Houry, in a resignation letter obtained by NBC News, wrote about the dangers of the spread of vaccine misinformation and said proposed budget cuts and reorganization plans would negatively impact the CDC’s ability to address conditions like hypertension, diabetes, cancer, overdoses and mental health issues.
In his resignation letter, also obtained by NBC News, Daskalakis said he was leaving the agency “because of the ongoing weaponizing of public health.”
Her departure comes at a tumultuous time for the agency, which is reeling from a gunman’s attack on its Atlanta headquarters on Aug. 8. A police officer died in the shooting.
Monarez on Friday canceled a meeting with CDC workers that had been scheduled for Monday, according to an email obtained by NBC News. She said she wanted to assure staff that the agency is working to restore their “trust in the safety and security of all CDC workplaces.”
President Donald Trump nominated Monarez after withdrawing his first pick to lead the CDC, former Republican congressman Dave Weldon, hours before his confirmation hearing. Weldon has been criticized for his views on vaccines.
— CNBC’s Michele Luhn contributed to this report.
-
Tech1 week ago
Korea develops core radar components for stealth technology
-
Business1 week ago
RSS Feed Generator, Create RSS feeds from URL
-
Fashion7 days ago
Tariff pressure casts shadow on Gujarat’s textile landscape
-
Fashion7 days ago
Rent the Runway to swap debt for equity in revival effort
-
jobs1 week ago
Data Analyst at Easy Agile – Australia
-
Fashion1 week ago
US retailers split on holiday prospects amid consumer caution
-
Tech7 days ago
Qi2’s Magnetic Wireless Charging Finally Arrives on Android
-
Sports1 week ago
Dan Quinn says Terry McLaurin is healthy, ‘closer’ to Commanders return